# Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer

> **NCT00124930** · PHASE3 · TERMINATED · sponsor: **Alberta Health services** · enrollment: 80 (estimated)

## Conditions studied

- Nausea
- Neoplasms

## Interventions

- **DRUG:** Olanzapine
- **DRUG:** Haldol

## Key facts

- **NCT ID:** NCT00124930
- **Lead sponsor:** Alberta Health services
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2005-05
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 80 (ESTIMATED)
- **Why stopped:** Study suspended due to low enrollment
- **Last updated:** 2012-01-19

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00124930

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00124930, "Study Comparing Olanzapine With Haloperidol for the Relief of Nausea and Vomiting in Patients With Advanced Cancer". Retrieved via AI Analytics 2026-09-12 from https://api.ai-analytics.org/clinical/NCT00124930. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*